LCN2 and metabolic syndrome: As previously reported, pregravid obesity resulted in increased plasma levels of metabolic hormones such as insulin, leptin, and lipocalin-2, indicative of insulin resistance, mild gestational hyperglycemia, and metabolic syndrome (Bo et al., 2004).